Targeted therapies, including ADCs, are revolutionizing chemotherapy delivery by improving precision and reducing systemic exposure, enhancing drug activity and potentially reactivating the immune ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...